MetaCap

Cypherpunk Technologies (CYPH) vs Faeth Therapeutics (FTH)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Faeth Therapeutics (FTH) has outperformed Cypherpunk Technologies (CYPH) over the past year, losing 9.6% versus a loss of 38.2%. Over five years, CYPH leads with a -94.4% price change compared with -95.0% for FTH. Cypherpunk Technologies is the larger company by market cap ($210.1 million vs $203.7 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CYPH-38.16%FTH-9.64%
+381%+141%-99%
Nov 21, 20251 yearNov 20, 2026
CYPH-93.79%FTH-95.34%
+50%-28%-106%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CYPH versus FTH key metrics
MetricCYPHFTH
Share price$1.41$7.88
Market cap$210.15M$203.65M
1-day change-18.02%-9.32%
YTD return+21.55%-26.15%
1-year return-38.16%-9.64%
5-year return-94.45%-94.96%
P/E ratio (TTM)0.67—
EPS (TTM)$2.09$-22.50
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Net income (latest FY)$4.82M$-21.09M
52-week high$4.19$42.14
52-week low$0.491$7.45
Distance from 52-week high-66.35%-81.30%
Analyst consensusstrong_buystrong_buy
Avg. price target upside+254.61%+612.56%
Average volume15.42M500.25K
Shares outstanding149.04M25.84M
Employees629
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • FTH has outperformed CYPH by 28.5 percentage points over the past year.

About Cypherpunk Technologies

CYPH stock →

Cypherpunk Technologies Inc., a privacy technology company, implements a digital asset strategy anchored by Zcash in the United States. The company is involved in identifying, developing, investing in, acquiring, and building privacy-enhancing technologies; and accumulating digital assets, such as ZCash.

Health Care · Biotechnology: Pharmaceutical Preparations · 6 employees

About Faeth Therapeutics

FTH stock →

Faeth Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company offers PIKTOR, an investigational multi-node inhibitor of the PI3K/AKT/mTOR pathway in development for endometrial and breast cancer.

Health Care · Biotechnology: Pharmaceutical Preparations · 29 employees

CYPH vs FTH FAQ

Which is bigger, Cypherpunk Technologies or Faeth Therapeutics?

Cypherpunk Technologies (CYPH) is larger, with a market capitalization of $210.15M compared with $203.65M for Faeth Therapeutics (FTH).

Which stock has performed better over the past year, CYPH or FTH?

FTH returned -9.64% over the past 12 months, compared with -38.16% for CYPH (price return, excluding dividends). Past performance does not predict future results.

Are Cypherpunk Technologies and Faeth Therapeutics in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons